About Bio-Path
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us
SEC Form 1-A
BPTH_Form_1-A_20250411
SEC: Withdrawal of Registration Statement on Form S-1
BPTH_25-3664-12__RW_20250409
SEC Form 8-K: Entry into a Material Definitive Agreement
BPTH_8-K_25-10724
SEC Form 8-K: Press Release dated March 28, 2025
BPTH20250327_8-K
SEC Form 10-K: For the fiscal year ended December 31, 2024
BPTH_Form_10-K_20250327
SEC Form 8-K: Press Release dated March 18, 2025
BPTH_20250318_8-K
SEC Form 8-K: Entry into a Material Definitive Agreement
BPTH_8-K_20250307
SEC Form 8-K
BPTH_20250217_8-K
SEC Form S-1/A
BPTH._S-1_A _20250212
SEC Form S-1
BPTH_S-1_20250121
About Bio-Path
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us